Direct-to-Patient Survey Results Summary
Health Care, Innovation, Supply Chain
During the 2022 GCSG US conference in San Antonio, 65 attendees participated in our Direct-to-Patient (DtP) survey. While 2/3rd’s of the respondents represented pharmaceutical companies / sponsors, there is also a strong mix of input from service providers. Over 50% of participants also had experience with DtP. Though a need for technology improvements was noted, our industry’s adoption of patient centric services like DTP continues to boost the growth of decentralized trials.
Related Education Resources.
All ResourcesVideo on ACE Requirements
Topics: Pharma Industry, Strategic Planning
Video
Members
EU Clinical Trial Regulation 536/2014
Topic: Regulatory
Position Paper
Members
EAP 101: Introduction to EAP
Topics: Additional Concepts, Closeout, EAP, Execution, Forecasting / Planning, Project Management
Presentation
Members
